The US Food and Drug Administration (FDA) has published the first of its court-ordered regular updates on its premarket tobacco product application (PMTA) progress – and it has not gone down well with health lobbyists.
The FDA said in its report that it would not finish reviewing the remaining PMTA applications until at least June 2023, a delay groups such as the Truth Initiative and the American Heart Association say will harm public health.